How Protein Synthesis Actually Works
Proteins are made inside cells through a process called translation. You start with DNA, which holds the instructions for building every protein your organism needs. That DNA gets copied into messenger RNA, which then travels to ribosomes where the actual assembly happens. Amino acids are brought in by transfer RNA molecules, each one carrying a specific building block that matches the sequence in the mRNA. The ribosome reads that sequence codon by codon, links the amino acids together, and out comes a polypeptide chain that folds into a functional protein. It sounds straightforward because the central dogma of molecular biology frames it that way, but the reality is messier. A lot of people learning this stop at the basic textbook explanation and then get confused when they try to actually work with it in a lab setting. The gap between "DNA makes RNA makes protein" and what happens in practice is enormous.
What Are Proteins Synthesized
Technically, proteins are synthesized by ribosomes on the rough endoplasm reticulum or free-floating in the cytoplasm. But the real answer depends on what you're trying to do. If you're asking about natural cellular protein synthesis, it's a highly regulated process involving initiation, elongation, and termination phases. If you're asking about synthesizing proteins in a lab or industrial setting, you're looking at recombinant DNA technology, cell-free expression systems, or chemical peptide synthesis — three very different approaches with very different constraints. In my experience working with recombinant protein expression, the biggest mistake people make is assuming that cloning a gene into an expression vector guarantees they'll get the protein they want. It doesn't. I spent about three weeks troubleshooting a recombinant enzyme that kept precipitating out of solution right after induction. The gene sequenced correctly. The plasmid looked fine. The bacterial culture grew normally. But every time I ran a SDS-PAGE gel, the target band was there as an insoluble pellet. Turns out the protein was folding too aggressively in the E. coli cytoplasm and forming inclusion bodies before it could properly fold. I solved it by switching to a slower-expression strain at lower temperature and adding a solubility tag on the N-terminus. That added about two extra purification steps but got me a usable yield within a week. Here's something that isn't obvious from introductory biology courses: the codon usage of your gene matters more than most people realize. E. coli and human cells use the genetic code differently. Human genes often contain rare codons that E. coli barely has tRNAs for. When your ribosome hits those rare codons repeatedly, it stalls, the protein comes out truncated or misfolded, and you're left wondering why your expression failed. The fix is usually codon optimization — rewriting the gene sequence to match the host organism's preferred codon frequencies without changing the actual amino acid sequence. Commercial gene synthesis companies do this routinely now.
Another thing that trips people up is post-translational modification. Bacterial expression systems like E. coli don't do glycosylation, phosphorylation, or proper disulfide bond formation the way eukaryotic cells do. If your protein needs any of those modifications to be functional, expressing it in bacteria is the wrong choice. You'd need to move to a system like insect cells with baculovirus, yeast, or mammalian cell culture. Each one has trade-offs. Yeast is cheaper and grows faster but still doesn't replicate mammalian glycosylation patterns accurately. Mammalian cells give you the right modifications but are expensive, slow, and harder to scale. For small peptides under about 50 amino acids, you can skip living cells entirely and use solid-phase peptide synthesis. That's a chemical method where you build the protein backwards from the C-terminus to the N-terminus on a resin bead. It's fast, it doesn't require any cloning or cell culture, and you can incorporate non-natural amino acids with relative ease. The downside is that yield drops significantly past 50 residues, and you start dealing with aggregation and incomplete coupling reactions. Above 50 to 100 amino acids, most people go back to recombinant expression even if it's more work. If you're just trying to understand the fundamentals for a class, focus on the three stages of translation and make sure you can trace how a DNA sequence becomes an amino acid sequence using the genetic code table. If you're actually doing this in a lab, spend more time on the downstream stuff — purification, solubility, and whether your expression system can handle the modifications your protein actually needs. That's where things fall apart in practice.
Get the Full Details
